- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Institutional Culture and Sensitive Investigations
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Events 170 results
Webinar
4月 29, 2025
FCA Enforcement and Litigation: How Recent Decisions and Policy Announcements Signal Key Changes
Webinar
Webinar
4月 10, 2025
Combination, Personalized, and Advanced Therapy Medicinal Products
Webinar
Webinar
3月 20, 2025
Regulatory Exclusivities
Webinar
3月 13, 2025
Managing Turbulent Times: Use of Representation and Warranty Insurance in Healthcare M&A
Webinar
2月 20, 2025
Orphan and Pediatric Medicinal Products
Webinar
2月 19, 2025
Health Privacy and Security Developments: NY Health Privacy Law and Proposed Changes to HIPAA Security Rule
Webinar
2月 13, 2025
Impact of the 2024 Election on Pharmaceutical, Biologics and Device Manufacturers
Webinar
1月 29, 2025
Summary of FDA’s New Final Guidance: Scientific Information on Unapproved Uses
Webinar
1月 28, 2025
Food for Thought: What the Food & Beverage Industry Can Expect in 2025